Literature DB >> 2708911

Interactions of pseudorabies virus with swine alveolar macrophages: effects of virus infection on cell functions.

G Iglesias1, C Pijoan, T Molitor.   

Abstract

In order to assess the effect of pseudorabies virus (PRV) infection on the function of swine alveolar macrophages (AM), lung lavage cells were cultured, infected with one of six strains of PRV, and various activities were measured. Activity measurement included viability, phagocytosis of yeast, phagosome-lysosome fusion, phagocytosis of opsonized particles, and superoxide release. AM were infected with 5 x 10(-3) PFU/cell, and the comparative assessment of functions was performed at 18-20 h postinfection. Cell viability in PRV-infected cultures ranged from 79 to 94% of the viability in noninfected cultures. Phagocytosis of yeast was significantly reduced only in the AM cultures infected with the strain S-62. Phagosome-lysosome fusion was depressed in cultures infected with the strains S-62, 4892, 3816, and BUK. The phagocytosis of opsonized sheep red blood cells showed significant differences between noninfected and PRV-infected cultures in all cases except cultures infected with the strain PRV-C. The O2 release after stimulation with opsonized zymosan was significantly reduced in all the PRV-infected cultures. The effect of PRV infection on AM functions that are related to the bacterial activity of such cells suggests that PRV-induced AM dysfunction might have a role in the increased susceptibility of PRV-infected pigs to bacterial pneumonia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2708911      PMCID: PMC7166681          DOI: 10.1002/jlb.45.5.410

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  Acute transcriptomic changes in murine RAW 264.7 cells following pseudorabies virus infection.

Authors:  Chao Tong; Peng-Fei Fu; Sheng-Li Ming; Lei Zeng; He-Shui Zhu; Jiang Wang
Journal:  Arch Virol       Date:  2022-10-21       Impact factor: 2.685

2.  Actinobacillus pleuropneumoniae culture supernatants interfere with killing of Pasteurella multocida by swine pulmonary alveolar macrophages.

Authors:  W B Chung; L Bäckström; J McDonald; M T Collins
Journal:  Can J Vet Res       Date:  1993-07       Impact factor: 1.310

3.  Interaction of bovine respiratory syncytial virus with bovine alveolar macrophages in vivo: effects of virus infection upon selected cell functions.

Authors:  T W Olchowy; T R Ames; T W Molitor
Journal:  Can J Vet Res       Date:  1994-01       Impact factor: 1.310

4.  Study of the potential involvement of pseudorabies virus in swine respiratory disease.

Authors:  G J Iglesias; M Trujano; J Lokensgard; T Molitor
Journal:  Can J Vet Res       Date:  1992-01       Impact factor: 1.310

5.  Interaction of the European genotype porcine reproductive and respiratory syndrome virus (PRRSV) with sialoadhesin (CD169/Siglec-1) inhibits alveolar macrophage phagocytosis.

Authors:  Miet I De Baere; Hanne Van Gorp; Peter L Delputte; Hans J Nauwynck
Journal:  Vet Res       Date:  2012-05-25       Impact factor: 3.683

6.  Evaluation of suitable reference genes for gene expression studies in porcine alveolar macrophages in response to LPS and LTA.

Authors:  Mehmet Ulas Cinar; Mohammad Ariful Islam; Muhammad Jasim Uddin; Ernst Tholen; Dawit Tesfaye; Christian Looft; Karl Schellander
Journal:  BMC Res Notes       Date:  2012-02-18

7.  Experimental dual infection of specific pathogen-free pigs with porcine reproductive and respiratory syndrome virus and pseudorabies virus.

Authors:  I Shibata; S Yazawa; M Ono; Y Okuda
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2003-02

8.  Effects of pseudorabies virus infection upon cytotoxicity and antiviral activities of porcine alveolar macrophages.

Authors:  G Iglesias; C Pijoan; T Molitor
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1992-10       Impact factor: 2.268

Review 9.  Targeting the porcine immune system--particulate vaccines in the 21st century.

Authors:  Kenneth C McCullough; Artur Summerfield
Journal:  Dev Comp Immunol       Date:  2008-09-02       Impact factor: 3.636

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.